Cryo Cell International (CCEL) Total Non-Current Liabilities (2010 - 2026)

Cryo Cell International has disclosed Total Non-Current Liabilities across 17 years of filings, most recently posting $79.2 million for Q1 2026.

• In Q1 2026, Total Non-Current Liabilities rose 264.79% year-over-year to $79.2 million; the TTM figure through Feb 2026 stood at $79.2 million (up 264.79% YoY), while the FY2025 annual figure was $19.8 million, down 74.57% from the prior year.
• Total Non-Current Liabilities advanced to $79.2 million in Q1 2026, from $19.8 million in the prior quarter.
• Over the last five years, Total Non-Current Liabilities for CCEL reached as high as $79.2 million in Q1 2026 and fell as low as $17.4 million in Q3 2024.
• The 5-year median for Total Non-Current Liabilities is $50.0 million (2022), against an average of $45.7 million.
• Annual changes were most pronounced in 2024 — Total Non-Current Liabilities plunged 74.67% — and 2025, when it surged 347.43%.
• A 5-year view of Total Non-Current Liabilities shows it stood at $19.5 million in 2022, then gained by 7.1% to $20.9 million in 2023, then jumped by 273.11% to $77.8 million in 2024, then tumbled by 74.57% to $19.8 million in 2025, then jumped by 300.33% to $79.2 million in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $79.2 million, $19.8 million, and $78.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.